Cargando…
Evaluating the potential of chelation therapy to prevent and treat gadolinium deposition from MRI contrast agents
Several MRI contrast agent clinical formulations are now known to leave deposits of the heavy metal gadolinium in the brain, bones, and other organs of patients. This persistent biological accumulation of gadolinium has been recently recognized as a deleterious outcome in patients administered Gd-ba...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5849765/ https://www.ncbi.nlm.nih.gov/pubmed/29535330 http://dx.doi.org/10.1038/s41598-018-22511-6 |